Alvogen is the next generation pharmaceuticals company. Our business model ensures competitive advantage through focused in-house capabilities and a network of partners for enhanced speed and flexibility. Alvogen currently has commercial operations in 35 countries around the globe, with regional hubs in North America, Romania and Taiwan.
Our passionate team is committed to continue to grow our business around the world and to becoming a top 10 global generic pharmaceuticals player. North America is our largest market with over 79 pending ANDA filings. Other markets include Romania, Hungary, Korea, Taiwan, Bulgaria, Japan, China and Russia.
Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safely to market.
Alvogen's lines of business include: product development, contract manufacturing and research (CMO), and sales of generic medicines (Gx and Hx), biosimilars and OTC’s.
Alvogen's product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology in addition to a fast growing portfolio of biosimilars and OTC products.
Our vision is to become the Preferred Partner by setting a new standard for the future of pharma. Five main pillars support our ambitious growth strategy and are the foundation for the Alvogen Star-Map, which serves as the framework for our focus areas and the actions that are needed to become a global leader.
Alvogen has commercial operations in more than 30 countries, with regional hubs, manufacturing and R&D capabilities in the U.S., South Korea and Romania.
Alvogen has 350 generic products on the market, with over 200 strategically selected development projects in the pipeline. Connect with local teams to learn more about product offering in your region.